design of future RCTs on the effectiveness of BtxA in spasticity can be improved only when goal oriented outcome measures are incorporated in the study design and when the design of RCTs is informed by data from qualitative and single case studies.
Single case study design has several advantages. 12 The subjects act as their own controls and all confounding variables, including personal, social, and environmental factors, remain constant. In addition, this research method permits the use of individualised outcome measures (for example, goal attainment scales) and allows flexibility in the treatment protocol (such as variations in the dose of BtxA and the choice of muscles for injection). This approach also deals better with the broad range of sensory and cognitive symptoms in the stroke population that have an impact on motor function, such as unilateral neglect, anosognosia for hemiplegia, and so on. Although single case studies eliminate the confounding factors that are often seen in a rehabilitation setting, they do not take into account the patients' variability. This difficulty may be overcome by conducting a series of carefully designed single case studies to identify subgroups of patients who are likely to benefit from the specific treatment. The group of patients identified in this way can then be studied in an RCT.
In conclusion, a research method in rehabilitation is clinically relevant only if it addresses the impact of the intervention on functional abilities and social participation. Although RCTs are considered the gold standard in biomedical research, they may not be suitable as the most valid research method in cases of complex neurological disability unless the treatment effect is assessed with goal oriented outcome measures. Partial or full attainment of these goals would be the yardstick by which treatment success is confirmed. Single case studies and qualitative observational research are more likely to reflect the complexities of clinical practice and to help answer the research question more completely. One could argue that a series of single case studies is a useful prerequisite for stratification for RCTs in the context of rehabilitation research. 1 It is often used to screen for dementia caused by Alzheimer's disease and to grade dementia severity. From humble origins three decades ago, the MMSE has become the benchmark against which other cognitive instruments are routinely compared. Alternatives have been proposed to correct perceived limitations of the original; among these psychometric pretenders is the seven minute neurocognitive screening battery, or seven minute screen (7MS). 2 The 7MS is a rational concatenation of four tests, each sensitive to the presence of dementia (temporal orientation, cued recall, category fluency, and clock drawing). 2 Maastricht (this issue, pp 700-705). 3 The participants, who were referred to specialty clinics for memory complaints, may be different from patients in primary care settings. Exclusion criteria included psychoactive drug use, recent stroke, active neurological or medical disease, and current alcohol abuse. Primary comparisons were with a combined ''normal'' group: referrals with memory complaints where cognition proved to be intact, plus patients' relatives and friends without memory symptoms. Normal individuals were similar to demented patients in terms of age and education but probably differed from the general population from which referral cases arose.
The 7MS took about 12 minutes to administer (eight minutes for normal subjects, 16 minutes for patients with Alzheimer's disease), with additional time required for scoring. 3 Analyses were unadjusted for confounders of age, education, or sex, but receiver operator characteristic curves (a useful method of displaying sensitivity and EDITORIAL COMMENTARIES specificity information) favoured the 7MS over the MMSE in distinguishing Alzheimer's disease patients from normal individuals. Small numbers precluded comparisons between other specific diagnoses and normal subjects, but the 7MS was also superior when applied to an amalgamated non-Alzheimer's disease dementia group. 3 Non-demented patients with depression or other psychiatric diagnoses were often misclassified by both tests. Performance characteristics of the 7MS would certainly be reduced in the complex, messy world inhabited by most clinicians. Here, target populations often include people using psychoactive drugs and patients with depression, neurological or medical disease, or mild cognitive impairment without dementia.
How might the practitioner use the 7MS? This instrument is not intended to assess cognition comprehensively. If the goal is to preselect older patients who might benefit from detailed clinical assessment for dementia, the 7MS clearly outperforms the benchmark MMSE. Although not addressed by Meulen et al, it is likely that the 7MS would also provide a more precise measure of dementia severity in following longitudinal progression. Better sensitivity, specificity, and predictive value should be weighed against a longer administration time and reduced familiarity. It is not known how the 7MS might compare with other validated instruments-for example, the cognitive abilities screening instrument 4 or neuropsychological tasks from CERAD (the consortium to establish a registry for Alzheimer's disease). 5 Practitioners should carefully consider the purpose of cognitive screening. For example, clinical assessment for dementia is more commonly triggered by patient or caregiver complaints of cognitive impairment than by screening results. In some settings, however, 12 minutes could be a rewarding investment, suggesting a useful niche for the optimistically named 7MS. Psychogenic non-epileptic seizures pose a management problem P sychogenic non-epileptic seizures (PNES), while superficially resembling epileptic seizures, are not accompanied by the abnormal electrical discharges associated with epilepsy and cannot be explained by other medical conditions. Instead they are psychologically determined and, as patients with PNES may be misdiagnosed as having epilepsy, this disorder poses a considerable management problem. The development of a better understanding of the psychiatric characteristics of PNES patients and other risk factors associated with having PNES may not only assist, along with medical investigations, in the correct diagnosis of patients' attacks, but may also inform effective treatment.
Though personality disorder has been diagnosed in very variable proportions of PNES patients, and research in this area is complicated by the use of different psychiatric classification systems and measures, the most common diagnoses associated with PNES have been borderline, histrionic, avoidant, and antisocial personality disorder. 1 Given that not all PNES patients satisfy formal diagnostic criteria for personality disorder, a different approach to understanding personality pathology is adopted in the paper by Reuber et al in this issue, 2 who used the dimensional assessment of personality pathologybasic questionnaire (DAPP-BQ) to identify personality profiles in PNES patients. While indicating that PNES patients as a group have greater pathology of personality than people with epilepsy or healthy controls, Reuber et al also found that the PNES patients' scores on the DAPP-BQ did not form a single profile of personality traits. Instead they identified two large and one much smaller clusters of patients accounting for 84 of their sample of 85 PNES patients. The DAPP-BQ scores of the two larger clusters resembled the characteristics of borderline personality disorder and compulsive personality disorder, respectively. The third cluster of PNES patients had traits resembling the characteristics associated with avoidant personality; this cluster contained only four individuals.
While a diagnosis of personality disorder per se has been considered a poor prognostic factor in people with PNES, 1 Reuber et al's approach to personality measurement in individuals with PNES offers the opportunity of moving away from the requirement to make a formal diagnosis of personality disorder before considering personality as one of the factors predictive of outcome. Reuber et al report, on the basis of their retrospective data, that those PNES patients with personality traits resembling borderline personality disorder had worse outcome on follow up in terms of seizure freedom than did the cluster with traits resembling compulsive personality disorder, despite the fact that more of the former than of the latter group had received (unspecified) psychiatric treatment. Reuber et al also address the possible use of different psychotherapeutic techniques for patients
